Skip to main content

Guardian Pharmacy Services, Inc.

GRDN
Exchange
NYSE
Industry
Retail-Drug Stores and Proprietary Stores
SEC CIK
0001802255

No open-market purchases or sales by Guardian Pharmacy Services, Inc. insiders were filed in the last 90 days; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Guardian Pharmacy Services, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of GRDN: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders105112+7
Shares18.2M19.7M+1.49M (+8.2%)
Value$387.6M$515.2M+$127.6M (+32.9%)

New holders (23)

Institutions that held Guardian Pharmacy Services, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to GRDN in Q3 2025
InstitutionSharesValue% of portfolio
Valiant Capital Management, L.P.1,064,722$27.9M2.59%
Qube Research & Technologies Ltd96,285$2.53M0.00%
Jane Street Group, LLC68,328$1.79M0.00%
D. E. Shaw & Co., Inc.46,548$1.22M0.00%
Voleon Capital Management LP26,365$691.6K0.02%
Trexquant Investment LP26,216$687.6K0.01%
Counterpoint Mutual Funds LLC19,495$511.4K0.04%
Aquatic Capital Management LLC16,549$434.1K0.01%
Two Sigma Advisers, LP14,000$367.2K0.00%
Magnetar Financial LLC13,782$361.5K0.00%
UBS Asset Management Americas Inc11,491$301.4K0.00%
Price T Rowe Associates Inc10,476$275.0K0.00%
Invesco Ltd.10,457$274.3K0.00%
Schonfeld Strategic Advisors LLC8,041$210.9K0.00%
Janus Henderson Group PLC8,000$209.9K0.00%
SG Americas Securities, LLC5,072$133.0K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)4,400$115.4K0.00%
State of Alaska, Department of Revenue1,161$30.0K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.230$6.00K0.00%
SRS Capital Advisors, Inc.100$2.62K0.00%
Advisory Services Network, LLC16$4200.00%
Allworth Financial LP12$3150.00%
Rakuten Investment Management, Inc.16,493––

Sold out (16)

Institutions that held Guardian Pharmacy Services, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.